Veeva Sys Inc Stock Price, News & Analysis

Veeva Systems (NYSE: VEEV) unveiled Veeva ePRO on October 18, 2022, enhancing patient-centric digital trials. This application streamlines patient assessments via mobile devices and web browsers, enabling sponsors and research sites to access real-time data. Addressing challenges like lengthy trial participation and redundant data entry, Veeva ePRO improves patient experience. Integrated within the Veeva Vault Clinical Suite, it facilitates seamless communication and tracking, offering benefits for both patients and trial sponsors.

On October 17, 2022, Veeva Systems (NYSE: VEEV) announced that 40 contract research organizations (CROs), including four of the top six global CROs, have adopted the Veeva Vault CTMS to enhance clinical trial efficiency. This solution is now used by over 120 sponsors, including nine of the top 20 pharmaceutical companies, establishing it as the industry leader in clinical trial management. The Vault CTMS provides a comprehensive view of trial metrics, improving collaboration and study performance, which is essential for accelerating trial processes.

Veeva Systems (NYSE: VEEV) announced the launch of two new applications, Link SiteBase and Link TrialBase, aimed at enhancing clinical trial design and site selection. Set for release in April and October 2023, respectively, Link SiteBase helps identify and rank research sites, while Link TrialBase provides critical clinical trial intelligence. The innovations are designed to address challenges in trial execution, such as intense competition and protocol complexity, delivering comprehensive data to speed up trial outcomes.

Veeva Systems (NYSE: VEEV) announced that over 350 companies are leveraging its Veeva Vault RIM Suite applications to enhance regulatory processes. In the past year, more than 65 emerging biotechs adopted these solutions to improve submission planning and compliance with evolving regulations. Notable advancements include Active Dossier management, label change tracking, and non-eCTD electronic publishing. A top 20 pharma streamlined 19 million data points through the platform, reducing SOPs by 90%. The suite's new features aim to accelerate time to market for submissions.

Veeva Systems (NYSE: VEEV) will host a virtual financial analyst and investor day on November 3, 2022. The event starts at 9:00 a.m. PT and ends around 11:00 a.m. PT. Presentations will be broadcast live on the company's investor relations website, with an archived link available post-event. Interested participants can register online through the investor relations site. Veeva leads in cloud software for the life sciences sector, serving over 1,000 clients.

Veeva Systems (VEEV) announced two innovative Crossix solutions aimed at enhancing omnichannel marketing for life sciences companies. The HCP Trigger Data connects patient engagement data with healthcare professional visits, helping marketers prioritize outreach effectively. Meanwhile, Omnichannel Boost provides a unified view of HCP and patient engagement across various channels, optimizing marketing performance. These tools aim to deliver actionable insights that enhance patient outcomes and improve marketing strategies, leveraging data covering over 300 million lives in the U.S.

Veeva Systems (NYSE: VEEV) announced that Batavia Biosciences has selected its Veeva Vault Quality Suite to enhance global quality assurance (QA). The cloud-based platform will streamline QA processes, facilitating real-time insights for better compliance and inspection readiness. Batavia, a Dutch CDMO specializing in viral vaccines, aims to optimize QA management through centralized documentation and training. Veeva's solutions will improve collaboration, reactiveness to quality events, and scalability of QA oversight across operations.

Veeva Systems (NYSE: VEEV) announced the upcoming Veeva R&D and Quality Summit on October 19-20 in Boston, featuring keynote speakers from major industry players like AbbVie, AstraZeneca, and GSK. This event will gather over 2,000 professionals and include more than 100 sessions focused on enhancing the efficiency of clinical trials and regulatory operations. Attendees will explore strategies for data management, quality transformation, and safety enhancements. Veeva emphasizes industry collaboration to drive innovation in the life sciences sector.

Veeva Systems (NYSE: VEEV) announces its 2022 Veeva Industries Virtual Summit, scheduled for Oct. 24-27. Leaders from major companies like Unilever, Reckitt, and Estée Lauder will discuss digital strategies to boost innovation and accelerate product market entry. The event features over 15 sessions focused on leveraging digital systems in quality, regulatory, and advertising claims.

Experts will explore how these technologies enhance supply chain resilience and foster sustainable product development. Attendance is complimentary for Veeva customers and qualified professionals.